SARON trial shows 56% improvement over standard treatment
Gen therapy
The clinical trials industry is embracing next-gen FSP mod...
News
Mad for it
MAD World Summit 2026 has secured official accreditation from The CPD Group
Microbiotica presents phase 1b data for MB097 at ESMO 2026
Early responses suggest restored sensitivity to anti‑PD‑1 therapy
FDA approves Hibsago for chronic hepatitis B
First-in-class therapy offers functional cure potential
FDA approves Enspryng for at‑home TED treatment
First SC option offers new flexibility for patients
EU approves teclistamab monotherapy for earlier myeloma use
Second-line authorisation expands immunotherapy options
Web Exclusives
True colours
The gold standard in spectroscopy
Trust issues
Specialty pharmacies – a guide to regulatory bodies and standards
Leader of the packs
3 Packaging Companies that offer custom pharmaceutical packaging solutions
Fertile ground
Top-rated pharmacies in northern Virginia for personalised fertility care
Magazine
Gen therapy
The clinical trials industry is embracing next-gen FSP models
A new hope
Wales is a leading location for paediatric oncology trials
Spin city
The business of science is being failed by scientists
Bold rush
Finding the real competitive advantage in pharma’s AI race
You can call me AI?
Pilots to patient impact – what healthcare needs to get right
Here to maternity
The challenge is getting technology it into maternity care
Look who’s talking
Jess has an illuminating chat with Moderna’s Emma Gilgunn-Jones
The hurdles
Ten things to know about the Single National Formulary
Thought Leadership
Investor horizons ahead of CPHI 2026
Key CDMO trends shaping strategies in a shifting global market
Buried knowledge could cost pharma billions. Here’s how to fix it
A global pharmaceutical company already has the competitive report it needs. The problem is that the report is buried...
Building the future of clinical research around the patients it serves
Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world...
Evolution
Future-ready pharma teams: building knowledge and capability to navigate a changing NHS
Webinars
Appointments
Eric Muller
Lucid Group appointed Eric Muller as Chief Executive Officer
Andrew Fenny
Andrew Fenny has been appointed President of Pace Life Sciences
Khatera Alawi
DFE Pharma has made Khatera Alawi Global Director HR
Dr Mai-Britt Zocca
Elevara Medicines has appointed Dr Mai-Britt Zocca as CEO
